Herpes simplex virus infection of mammalian hosts involves lytic replication at a primary site, such as the cornea, translocation by axonal transport to sensory ganglia and replication, and latent infection at a secondary site, ganglionic neurons. The virus-encoded thymidine kinase, which is a target for antiviral drugs such as acyclovir, is not essential for lytic replication yet evidently is required at the secondary site for replication and some phase of latent infection. To determine the specific stage in viral pathogenesis at which this enzyme is required, we constructed virus deletion mutants that were acyclovir resistant and exhibited no detectable thymidine kinase activity. After corneal inoculation of mice, the mutants replicated to high titers in the eye but were severely impaired for acute replication in trigeminal ganglia and failed to reactivate from ganglia upon cocultivation with permissive cells. Nevertheless, latency-associated transcripts were expressed in neuronal nuclei of ganglia from mutantinfected mice and superinfection of the ganglia with a second virus rescued the latent mutant virus. Thus, contrary to a widely accepted hypothesis, the thymidine kinase-negative mutants established latent infections, implying that neither thymidine kinase activity nor ganglionic replication is necessary for establishment of latency. Rather, thymidine kinase appears to be necessary for reactivation from latency. These results suggest that acyclovir-resistant viruses could establish latent infections in clinical settings and have implications for the use of genetically engineered herpesviruses to deliver foreign genes to neurons.
Infection of mammalian hosts by herpes simplex virus (HSV)
involves several stages. Initially, the virus replicates lytically at a primary site in the skin, cornea, or mucosa. The virus then gains access to nerve terminals and is transported by axonal transport to the secondary site of replication, sensory ganglia. Subsequently, HSV can establish and maintain a latent infection in ganglionic neurons during which infectious virus is not detectable and viral gene expression and DNA replication are severely restricted (1) (2) (3) (4) (5) (6) . In humans, reactivation of virus from latent infections is responsible for recurrent episodes of disease. Latent infections cannot be cured by currently available antiviral drugs including acyclovir (2) (3) (4) (5) (6) (7) (8) .
HSV encodes at least 70 proteins (9) , of which 30-40 are required for lytic replication in growing mammalian cells (10) . The HSV-encoded thymidine kinase (tk), which phosphorylates deoxypyrimidine nucleosides and nucleoside analogs such as acyclovir, is among those viral gene products that are not required for lytic replication (11) (12) (13) . Furthermore, studies in mice have shown that tk is not required for replication at the primary site of infection, at least when that site is the cornea. These studies have suggested instead that tk is required both for acute ganglionic replication and reactivatable latent ganglionic infections (for review, see refs. 3 and 6). Thus, tk appears to have evolved, at least in part, to function in the interaction of HSV with the ganglionic neuron, which is the site for three stages in HSV pathogenesis-secondary replication, latency, and reactivation.
A widely accepted hypothesis (14) (15) (16) for the role of tk in these stages of HSV pathogenesis is that tk is required for the establishment of infection of ganglionic neurons. However, it has not been technically possible until recently to distinguish between a requirement for tk during establishment of infection and a requirement at later stages such as reactivation from latency or a requirement during earlier events such as transport of viral DNA to neuronal nuclei (for review, see ref. 6 ). Moreover, certain mutant viruses have been described that express little or no tk, yet establish reactivatable latent infections in mice (17-21). Thus, a definitive role for tk in latent infection has not been determined.
The role of tk in viral pathogenesis is of special clinical interest because tk-deficient mutants are resistant to the widely used anti-HSV drug, acyclovir. This resistance stems from the requirement for viral tk to activate acyclovir efficiently (12, 13, (22) (23) (24) (25) . Such tk-deficient, acyclovir-resistant mutants can arise during treatment of human herpesvirus infections with acyclovir, especially in immunocompromised patients, and increasingly have been associated with poor response to acyclovir therapy (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Iftk is not required for the establishment of latent infection, acyclovir-resistant mutants may be able to persist in an infected patient. Moreover, there are anti-HSV drugs under development that are designed to block viral replication in mammalian hosts by inhibition oftk (36, 37) and thus depend upon an essential role for tk during human infections.
To define more precisely the role of tk in HSV pathogenesis, we constructed tk-negative mutants containing defined lesions in the tk gene and tested these viruses in a mouse eye model for acute replication in the eye and trigeminal ganglia and for reactivatable latent infections. The finding that specific RNA species (latency-associated transcripts, LAT) are prominent in latently infected neurons (38) (39) (40) (41) (42) (44) . The replication-incompetent ICP27 deletion mutant 5dll.2 was propagated and assayed on 3.3 cells as described by McCarthy et al. (45) .
To construct dlsptk, a plasmid containing HSV strain KOS sequences from the Bgl II site (Fig. 1) to the Pvu II site downstream of the tk gene was digested to completion with Pst I and Sph I and treated with T4 DNA polymerase to remove 3' overhanging sequences. The larger fragment was purified from an agarose gel, recircularized with T4 DNA ligase, and used to transform Escherichia coli. Bacterial colonies containing a plasmid with the appropriate deletion were identified by restriction enzyme mapping. One such plasmid was transfected into Vero cells with infectious KOS DNA as described (49) . Progeny virus were plated at 370C in 100 uM acyclovir; plaques resistant to acyclovir were picked and screened for the deletion mutation as described (50) after BamHI digestion. Two independently derived isolates were obtained.
To construct dlsactk, pKOS17B2 (44) Plaque reduction assays to measure susceptibilities to acyclovir were performed as described (51) . tk assays were performed as described (22, 23) using 143 cells.
Assays of Acute and Latent Infections in Mice. Acute virus titers in the eye and trigeminal ganglia and reactivatable latent infections in trigeminal ganglia were assayed after corneal inoculation of CD-1 mice (Charles River Breeding Laboratories) as described (21, 43) .
In Situ Hybridization. The methods used for in situ hybridization have been described (52, 53) . The labeled doublestranded DNA probe used in Fig. 3 was plasmid pIPH containing a 1.4-kilobase-pair Pst I-Hpa I fragment from the LAT coding sequences. Similar results were obtained with labeled purified insert DNA sequences from pIPH.
Superinfection-Rescue Assays. Rescue of virus from latently infected ganglia by superinfection with HSV mutant 5dll.2 was performed as described by Leib et al. (43) . Briefly, ganglia were removed from mice infected 30 days previously, dissociated, and the dissociated cells infected at high multiplicity with 5dll.2. Vero cells in suspension were then added and allowed to settle. A methylcellulose overlay was then added. After plaques formed, they were visualized with neutral red, counted, and picked. Viral DNA was obtained from plaque isolates and analyzed by Southern blot hybridization as described (50 (Fig. 2) . Titers of mutant viruses in the eye declined to lower levels more quickly during the next 3 days than did the titer of wild-type virus (Fig. 2) . reactivation by co-cultivation in the presence of 200 mM dimethyl sulfoxide, a treatment that greatly enhances the reactivation frequency of certain wild-type strains and mutants from latently infected ganglia (43, 55) . However, no virus was recovered from ganglia from mice infected with either of the tk mutants reactivated under these conditions (Table 1) . Thus, the two deletion mutants were unable to reactivate from latent infections in agreement with most past studies of mutants that do not express detectable levels of tk (for review, see ref. 6 ).
The tk Mutant Viruses Express LAT. The results just described left unanswered the question of whether the tk mutants were defective in their ability to reactivate from latent infections or at earlier stages, such as their ability to establish latency. To address this question, we first examined mutant-infected ganglia for LAT expression. Mice were mock-infected or infected with KOS or with either of the tk deletion mutants. Thirty days later, ganglia were sectioned and prepared for in situ hybridization with a radiolabeled plasmid containing sequences encoding LAT. As shown in Fig. 3 , no signal was detected in ganglionic sections from mock-infected mice, whereas silver grains were concentrated over neuronal nuclei in ganglionic sections from mice infected with either KOS or mutant dlsactk. Similar hybridization was observed in ganglionic sections from mice infected with mutant dlsptk (data not shown). The numbers of grains per nucleus were similar in sections from mice infected with wild-type virus or tk deletion mutants. No specific signal ganglia, we performed a superinfection rescue assay (43) . Sixteen ganglia from mice that had been infected 30 days previously with dlsactk were dissociated and superinfected with a replication-incompetent mutant, 5d11.2. The superinfected ganglion cells were then tested for their ability to give rise to plaques when mixed with Vero cells. All 16 superinfected ganglia yielded HSV plaques, with a mean of 29 plaques per ganglion (Table 3) . Southern blot analysis of DNA from six individual plaque isolates indicated the presence of both mutant and undeleted tk alleles, demonstrating that the recovered virus resulted from complementation, recombination, or both following superinfection (unpublished results). In contrast, no virus was recovered after mock superinfection of ganglia from mice infected 30 days previously with dlsactk or after superinfection with 5d11.2 of ganglia from mice that were mock-infected 30 days previously (Table 3 ). These results demonstrate that the tk mutant Fig. 3 or experiments using probes including sequences flanking LATencoding sequences.
DNA was present in ganglia in a biologically retrievable state through 30 days after infection.
DISCUSSION
HSV tk is an example of a viral gene product that has a stage-specific role in pathogenesis. In the mouse eye model, it is required at some point after primary replication at the site of inoculation. We sought to define the role of tk more precisely. Our results demonstrate that after corneal inoculation with tk-negative mutants, viral DNA can reach neuronal nuclei in trigeminal ganglia, be maintained in a biologically retrievable state, and express LAT. We conclude from these results that tk-negative mutants establish latent infections.
We conclude further that tk activity is not required for establishment of latent infections. This conclusion differs from the widely accepted hypothesis (14-16) that tk is necessary for establishment of neuronal infection. Rather, it appears that tk-negative mutants can infect ganglionic neurons but do not multiply within them.
Because tk-negative mutants are severely impaired for acute ganglionic replication yet still establish latency, we conclude that acute ganglionic replication is not required for establishment of latent infections. This conclusion is consistent with suggestions derived from earlier experiments with temperature-sensitive mutants, antiviral drugs, and circulating antibody (for review, see refs. 2-6). However, the finding of larger numbers of LAT-positive neurons in wild-type infected ganglia (Table 2 ) and detection of more HSV DNA in wild-type infected ganglia than in tk mutant-infected ganglia (K. Hicks, D. Yager, J. Katz, and D.M.C., unpublished results) could be interpreted to suggest that acute ganglionic replication serves to increase the number of cells harboring latent virus and/or the number of latent viral genomes. Alternatively, the greater amount of wild-type virus in the eye after day 2 (Fig. 2 ) may contribute to these differences.
Our results strongly suggest that tk is required specifically for reactivation from latent infections. In the case of dlsptk, we infer that the decline in levels of virus in the eye on days 2-4 after infection, the severely diminished titers in ganglia during the same period and failure to reactivate from latent infections are all due to the deletion mutation because indistinguishable results were obtained with two independent isolates of this mutant (unpublished results). A requirement for tk could be explained if there is a requirement for sufficient pools of its enzymatic products, deoxypyrimidine nucleotides, in each of these settings to permit viral DNA replication. We cannot, however, exclude other reasons for a requirement for tk.
Clinical Implications. Acyclovir-resistance is a problem of growing clinical importance as the numbers of immunocompromised patients increase due to AIDS, transplants, and cancer chemotherapy (56) . Acyclovir-resistant tk-deficient viruses have been isolated from patients, some of whom had poor responses to acyclovir (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) 
